273 related articles for article (PubMed ID: 11925101)
1. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
Danielsen AJ; Maihle NJ
Exp Cell Res; 2002 Apr; 275(1):9-16. PubMed ID: 11925101
[TBL] [Abstract][Full Text] [Related]
2. Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis.
Boerner JL; Danielsen AJ; Lovejoy CA; Wang Z; Juneja SC; Faupel-Badger JM; Darce JR; Maihle NJ
Oncogene; 2003 Oct; 22(43):6679-89. PubMed ID: 14555981
[TBL] [Abstract][Full Text] [Related]
3. Membrane localization of v-ErbB is required but not sufficient for ligand-independent transformation.
Danielsen AJ; Christensen TA; Lovejoy CA; Adelsman MA; Connolly DC; Maihle NJ
Exp Cell Res; 2004 Jun; 296(2):285-93. PubMed ID: 15149858
[TBL] [Abstract][Full Text] [Related]
4. The erbB gene and the EGF receptor.
Martin GS
Cancer Surv; 1986; 5(2):199-219. PubMed ID: 2877733
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor.
Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA
Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors.
Haley JD; Hsuan JJ; Waterfield MD
Oncogene; 1989 Mar; 4(3):273-83. PubMed ID: 2784850
[TBL] [Abstract][Full Text] [Related]
8. Cell transformation by the epidermal growth factor receptor and v-erbB.
Hayman MJ; Enrietto PJ
Cancer Cells; 1991 Aug; 3(8):302-7. PubMed ID: 1681843
[TBL] [Abstract][Full Text] [Related]
9. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis.
von Lindern M; Deiner EM; Dolznig H; Parren-Van Amelsvoort M; Hayman MJ; Mullner EW; Beug H
Oncogene; 2001 Jun; 20(28):3651-64. PubMed ID: 11439328
[TBL] [Abstract][Full Text] [Related]
10. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.
Lonardo F; Di Marco E; King CR; Pierce JH; Segatto O; Aaronson SA; Di Fiore PP
New Biol; 1990 Nov; 2(11):992-1003. PubMed ID: 1983208
[TBL] [Abstract][Full Text] [Related]
11. EGF promotes in vivo tumorigenic growth of primary chicken embryo fibroblasts expressing v-myc and enhances in vitro transformation by the v-erbA oncogene.
Khazaie K; Panayotou G; Aguzzi A; Samarut J; Gazzolo L; Jurdic P
Oncogene; 1991 Jan; 6(1):21-8. PubMed ID: 1671532
[TBL] [Abstract][Full Text] [Related]
12. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.
McCubrey JA; Shelton JG; Steelman LS; Franklin RA; Sreevalsan T; McMahon M
Oncogene; 2004 Oct; 23(47):7810-20. PubMed ID: 15361836
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
[TBL] [Abstract][Full Text] [Related]
14. An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex.
McManus MJ; Boerner JL; Danielsen AJ; Wang Z; Matsumura F; Maihle NJ
J Biol Chem; 2000 Nov; 275(45):35328-34. PubMed ID: 10954714
[TBL] [Abstract][Full Text] [Related]
15. Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential.
Zhang HT; O'Rourke DM; Zhao H; Murali R; Mikami Y; Davis JG; Greene MI; Qian X
Oncogene; 1998 Jun; 16(22):2835-42. PubMed ID: 9671404
[TBL] [Abstract][Full Text] [Related]
16. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
Kapoor GS; Kapitonov D; O'Rourke DM
Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the role of the carboxy-terminal region of the v-erbB protein in erythroid cell transformation.
Lee EB; Beug H; Hayman MJ
Oncogene; 1993 May; 8(5):1317-27. PubMed ID: 8097581
[TBL] [Abstract][Full Text] [Related]
19. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1.
Bosch E; Cherwinski H; Peterson D; McMahon M
Oncogene; 1997 Aug; 15(9):1021-33. PubMed ID: 9285556
[TBL] [Abstract][Full Text] [Related]
20. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
Basso J; Briggs J; Findlay C; Bos T
Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
